HNSCC,LARYNX, PHARYNX AND ORAL CAVITY
Clinical trials for HNSCC,LARYNX, PHARYNX AND ORAL CAVITY explained in plain language.
Never miss a new study
Get alerted when new HNSCC,LARYNX, PHARYNX AND ORAL CAVITY trials appear
Sign up with your email to follow new studies for HNSCC,LARYNX, PHARYNX AND ORAL CAVITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Glow-in-the-Dark dye could help surgeons spot hidden cancer
Knowledge-focused Recruiting nowThis early-phase trial tests a fluorescent dye attached to the cancer drug panitumumab to help surgeons see head and neck cancer during surgery. 18 adults with head and neck squamous cell carcinoma will receive the dye before surgery, and a special camera will highlight cancer ti…
Matched conditions: HNSCC,LARYNX, PHARYNX AND ORAL CAVITY
Phase: EARLY_PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
New scanner could help surgeons remove all cancer in one go
Knowledge-focused Recruiting nowThis study tests a high-resolution PET-CT scanner that images removed tumors right in the operating room. About 50 adults with solid cancers will get a standard PET tracer before surgery, then the removed tissue is scanned to see if all cancer was taken out. The goal is to see if…
Matched conditions: HNSCC,LARYNX, PHARYNX AND ORAL CAVITY
Phase: NA • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC